• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士西南部献血者中戊型肝炎病毒血清流行率。

Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.

机构信息

Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

出版信息

PLoS One. 2011;6(6):e21150. doi: 10.1371/journal.pone.0021150. Epub 2011 Jun 20.

DOI:10.1371/journal.pone.0021150
PMID:21701586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3118806/
Abstract

AIM

The aim of this study was to determine the seroprevalence of Hepatitis E virus (HEV) among blood donors in southwest Switzerland.

BACKGROUND

HEV is recognized as a food-borne disease in industrialized countries, transmitted mainly through pork meat. Cases of transmission through blood transfusion have also been reported. Recent studies have revealed seroprevalence rates of 13.5%, 16.6% and 20.6% among blood donors in England, France and Denmark, respectively.

METHODS

We analyzed 550 consecutive blood donor samples collected in the region of Lausanne, canton of Vaud, Switzerland, for the presence of anti-HEV IgG, using the MP Diagnostics HEV ELISA kit. For each donor, we documented age, sex and alanine aminotransferase (ALT) value.

RESULTS

The study panel was composed of 332 men (60.4%) and 218 women (39.6%). Overall, anti-HEV IgG was found in 27 of 550 samples (4.9%). The seroprevalence was 5.4% (18/332) in men and 4.1% (9/218) in women. The presence of anti-HEV IgG was not correlated with age, gender or ALT values. However, we observed a peak in seroprevalence of 5.3% in individuals aged 51 to 70 years old.

CONCLUSIONS

Compared with other European countries, HEV seroprevalence among blood donors in southwest Switzerland is low. The low seroprevalence may be explained by the sensitivity of commercial tests used and/or the strict regulation of animal and meat imports. Data regarding HEV prevalence in Swiss livestock are lacking and merit exploration.

摘要

目的

本研究旨在确定瑞士西南部献血者中戊型肝炎病毒(HEV)的血清流行率。

背景

HEV 在工业化国家被认为是一种食源性疾病,主要通过猪肉传播。也有报道通过输血传播的病例。最近的研究显示,英国、法国和丹麦的献血者血清流行率分别为 13.5%、16.6%和 20.6%。

方法

我们使用 MP Diagnostics HEV ELISA 试剂盒分析了瑞士沃州洛桑地区采集的 550 例连续献血者样本,以检测抗-HEV IgG 的存在。对于每个献血者,我们记录了年龄、性别和丙氨酸氨基转移酶(ALT)值。

结果

研究组由 332 名男性(60.4%)和 218 名女性(39.6%)组成。总体而言,在 550 个样本中有 27 个(4.9%)检测到抗-HEV IgG。男性的血清流行率为 5.4%(18/332),女性为 4.1%(9/218)。抗-HEV IgG 的存在与年龄、性别或 ALT 值无关。然而,我们观察到 51 至 70 岁年龄组的血清流行率峰值为 5.3%。

结论

与其他欧洲国家相比,瑞士西南部献血者的 HEV 血清流行率较低。低血清流行率可能是由于使用的商业检测的敏感性以及对动物和肉类进口的严格监管所致。瑞士牲畜中关于 HEV 流行率的数据尚不清楚,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae7/3118806/549854f33c23/pone.0021150.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae7/3118806/549854f33c23/pone.0021150.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae7/3118806/549854f33c23/pone.0021150.g001.jpg

相似文献

1
Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.瑞士西南部献血者中戊型肝炎病毒血清流行率。
PLoS One. 2011;6(6):e21150. doi: 10.1371/journal.pone.0021150. Epub 2011 Jun 20.
2
Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016.瑞士献血者中当前戊型肝炎病毒血清流行率及 1997 年至 2016 年的明显下降趋势。
Euro Surveill. 2018 Aug;23(35). doi: 10.2807/1560-7917.ES.2018.23.35.1700616.
3
Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.五种商业检测方法评估献血者中抗 HEV 抗体血清阳性率的性能评估。
J Med Microbiol. 2018 Sep;67(9):1302-1309. doi: 10.1099/jmm.0.000807. Epub 2018 Jul 27.
4
Hepatitis E virus seroprevalence and molecular study among blood donors in China.中国献血人群中戊型肝炎病毒血清流行率及分子研究。
Transfusion. 2014 Mar;54(3 Pt 2):910-7. doi: 10.1111/trf.12530. Epub 2013 Dec 24.
5
Seroprevalence and incidence of hepatitis E virus infection in German blood donors.德国献血者中戊型肝炎病毒感染的血清流行率和发病率。
Transfusion. 2014 Jan;54(1):49-56. doi: 10.1111/trf.12121. Epub 2013 Feb 26.
6
Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017.2017 年法国科西嘉岛献血者中戊型肝炎病毒的血清流行率。
Euro Surveill. 2020 Feb;25(5). doi: 10.2807/1560-7917.ES.2020.25.5.1900336.
7
Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors.克罗地亚献血者中戊型肝炎检测相关血清流行率的估计。
Transfus Clin Biol. 2019 Nov;26(4):229-233. doi: 10.1016/j.tracli.2019.06.234. Epub 2019 Jun 24.
8
A Nationwide Survey of the Seroprevalence of Hepatitis E Virus Infections Among Blood Donors in Thailand.泰国献血人群中戊型肝炎病毒感染血清流行率的全国性调查。
Viral Immunol. 2019 Sep;32(7):302-307. doi: 10.1089/vim.2018.0146. Epub 2019 Aug 12.
9
Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors.塞尔维亚献血者中戊型肝炎病毒(HEV)抗体的流行情况。
J Infect Dev Ctries. 2014 Oct 15;8(10):1322-7. doi: 10.3855/jidc.4369.
10
Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients.4023 例免疫功能低下患者队列中戊型肝炎病毒感染的流行病学。
Int J Infect Dis. 2020 Feb;91:188-195. doi: 10.1016/j.ijid.2019.11.014. Epub 2019 Nov 20.

引用本文的文献

1
Hepatitis E virus infections among patients with acute febrile jaundice in two regions of Cameroon: First molecular characterization of hepatitis E virus genotype 4.喀麦隆两个地区急性发热性黄疸患者中的戊型肝炎病毒感染:戊型肝炎病毒 4 基因型的首次分子特征描述。
PLoS One. 2024 Feb 12;19(2):e0298723. doi: 10.1371/journal.pone.0298723. eCollection 2024.
2
Epidemiology of HEV Infection in Blood Donors in Southern Switzerland.瑞士南部献血者中戊型肝炎病毒感染的流行病学
Microorganisms. 2023 Sep 22;11(10):2375. doi: 10.3390/microorganisms11102375.
3
Hepatitis E Virus (HEV) Infection among Hemodialysis Patients from Southern Bulgaria.

本文引用的文献

1
Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.瑞士 HIV 感染者中戊型肝炎病毒血清流行率和慢性感染情况。
Emerg Infect Dis. 2011 Jun;17(6):1074-8. doi: 10.3201/eid/1706.101067.
2
A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.两种市售抗-HEV IgG 试剂盒的比较及发达国家抗-HEV IgG 血清流行率数据的再评估。
J Med Virol. 2010 May;82(5):799-805. doi: 10.1002/jmv.21656.
3
Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review.
保加利亚南部血液透析患者中的戊型肝炎病毒(HEV)感染
Pathogens. 2023 Sep 30;12(10):1208. doi: 10.3390/pathogens12101208.
4
Exploring hepatitis E virus seroprevalence and associated risk factors among the human population in Tandil, Buenos Aires, Argentina.探讨阿根廷布宜诺斯艾利斯省坦迪尔市人群中戊型肝炎病毒血清流行率及其相关危险因素。
Front Public Health. 2023 Oct 5;11:1257754. doi: 10.3389/fpubh.2023.1257754. eCollection 2023.
5
Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis.与北美相比,欧洲和亚洲献血者中戊型肝炎病毒传播和暴露的风险更高:一项荟萃分析。
Pathogens. 2023 Mar 8;12(3):425. doi: 10.3390/pathogens12030425.
6
First Report of the HEV Seroprevalence and the Risk Factor Assessment in the West Bank, Palestine, during the Period of 2015-2017.2015 - 2017年期间巴勒斯坦约旦河西岸戊型肝炎病毒血清流行率及危险因素评估的首次报告
Can J Infect Dis Med Microbiol. 2022 Feb 8;2022:4935811. doi: 10.1155/2022/4935811. eCollection 2022.
7
Transfusion-transmitted hepatitis E: What we know so far?经输血传播的戊型肝炎:目前我们了解多少?
World J Gastroenterol. 2022 Jan 7;28(1):47-75. doi: 10.3748/wjg.v28.i1.47.
8
Hepatitis E Virus: An emerging enigmatic and underestimated pathogen.戊型肝炎病毒:一种新出现的神秘且被低估的病原体。
Saudi J Biol Sci. 2022 Jan;29(1):499-512. doi: 10.1016/j.sjbs.2021.09.003. Epub 2021 Sep 20.
9
Treatment induced clearance of hepatitis E viruses by interferon-lambda in liver-humanized mice.干扰素λ诱导肝人化小鼠中戊型肝炎病毒的清除。
Liver Int. 2021 Dec;41(12):2866-2873. doi: 10.1111/liv.15033. Epub 2021 Aug 29.
10
Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana.加纳猪和人类接触者中戊型肝炎病毒的血清分子流行病学
One Health Outlook. 2021 Jun 22;3(1):13. doi: 10.1186/s42522-021-00043-w.
欧洲本土型戊型肝炎病毒感染的传播途径和危险因素:系统评价。
Epidemiol Infect. 2010 Feb;138(2):145-66. doi: 10.1017/S0950268809990847. Epub 2009 Oct 6.
4
Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994.美国戊型肝炎病毒的流行病学:1988 - 1994年第三次全国健康和营养检查调查结果
J Infect Dis. 2009 Jul 1;200(1):48-56. doi: 10.1086/599319.
5
Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.一名正在服用利妥昔单抗的非霍奇金淋巴瘤患者感染戊型肝炎病毒后发生慢性肝炎。
Ann Intern Med. 2009 Mar 17;150(6):430-1. doi: 10.7326/0003-4819-150-6-200903170-00026.
6
Indigenous hepatitis E virus infection in England: more common than it seems.英格兰的戊型肝炎病毒本土感染:比看起来更常见。
J Clin Virol. 2009 Apr;44(4):272-6. doi: 10.1016/j.jcv.2009.01.005. Epub 2009 Feb 12.
7
Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.丹麦农民和献血者中戊型肝炎抗体流行率的时间趋势:一种潜在的人畜共患病
Clin Infect Dis. 2008 Oct 15;47(8):1026-31. doi: 10.1086/591970.
8
Hepatitis E virus.戊型肝炎病毒
Curr Opin Infect Dis. 2008 Oct;21(5):539-43. doi: 10.1097/QCO.0b013e32830ee08a.
9
Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease.英格兰西南部的本土戊型肝炎:自然史、并发症及季节性变化,以及献血者、老年人和慢性肝病患者中戊型肝炎病毒IgG血清阳性率
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):784-90. doi: 10.1097/MEG.0b013e3282f5195a.
10
Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A.英格兰西南部的本土戊型肝炎:与甲型肝炎的比较。
Eur J Clin Microbiol Infect Dis. 2008 Jul;27(7):579-85. doi: 10.1007/s10096-008-0480-z. Epub 2008 Feb 26.